Latest news
AbCellera Biologics Inc. (NASDAQ:ABCL) Analysts Just Slashed This Year's Revenue Estimates By 22% - simplywall.stsimplywall.st · Mon, 10 Aug 2026 11:08:52 GMTS&P 500 Q2 EPS and revenue growth beat expectat... - PluangPluang · Mon, 10 Aug 2026 11:08:16 GMTRecursion Pharmaceuticals, Inc. (NASDAQ:RXRX) Analysts Just Trimmed Their Revenue Forecasts By 19% - simplywall.stsimplywall.st · Mon, 10 Aug 2026 10:46:51 GMTBLS International reports 25.3% revenue growth in Q1 FY27 - ET TravelWorldET TravelWorld · Mon, 10 Aug 2026 10:33:51 GMTNESR: Q2 2026 saw strong revenue and profit growth, with robust liquidity and new capital return plans - TradingViewTradingView · Mon, 10 Aug 2026 10:19:02 GMTS&P 500 EPS / Revenue Growth, And Amazon Earnings - Seeking AlphaSeeking Alpha · Mon, 10 Aug 2026 10:05:00 GMTPLUS: Record H1 2026 results with 12% revenue growth and $370M in shareholder returns announced - TradingViewTradingView · Mon, 10 Aug 2026 10:03:45 GMTMSLH: Profit growth and margin recovery achieved despite flat revenue, with FY26 outlook maintained - TradingViewTradingView · Mon, 10 Aug 2026 09:34:31 GMT